SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike RBD Recombinant Protein
SARS-CoV-2 (COVID-19) Beta Variant (B.1.351, SA) Spike RBD Recombinant Protein
Product Specifications
Product Name Alternative
SARS-CoV-2 (COVID-19) Spike RBD Recombinnat Protein: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Surface Glycoprotein, Spike protein
UniProt
P0DTC2
Tag
C-terminal His tag
Source
HEK293 cells
Field of Research
Infectious Disease & Virology
Concentration
Batch dependent
Purity
>98% as determined by SDS-PAGE, see Fig. 1 A and B. PureCube Indigo Agarose.
Bioactivity
Not determined
Form
Liquid
Molecular Weight
225 amino acids (including His tag) ; 25506 Da
Storage Conditions
–80°C. Avoid freeze-thaw cycles
Notes
For research use only.
Applications Notes
This recombinant protein can be used for ELISA assays, Ligand binding assays (e.g. SPR), Biochemical and biophysical analyses. For research use only.
Tested Applications
ELISA
Preservative
20 mM Hepes pH 7.5; 150 mM NaCl
AA Sequence
Sequence (aa 319 – 537), N501YC-terminal His tag
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD106 / VCAM1 (B-K9), CF405S conjugate, 0.1mg/mL
Fibronectin (TV-1), CF740 conjugate, 0.1mg/mL
Ep-CAM / CD326 (VU-1D9), CF405S conjugate, 0.1mg/mL
Cytokeratin 17 (E3), CF647 conjugate, 0.1mg/mL
